# EDGAR Filing Document

**Accession Number:** 0001762303
**File Stem:** 0001193125-26-145150
**Filing Date:** 2026-4
**Character Count:** 2381
**Document Hash:** 868b96e405d9db4827940ea1da0d545d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-145150.hdr.sgml**: 20260507

**ACCESSION NUMBER**: 0001193125-26-145150

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260407

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AVITA Medical, Inc.
- **CENTRAL INDEX KEY:** 0001762303
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 202578762
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 28159 AVENUE STANFORD
- **STREET 2:** SUITE 220
- **CITY:** VALENCIA
- **STATE:** CA
- **ZIP:** 91355
- **BUSINESS PHONE:** 661-568-1317

**MAIL ADDRESS:**
- **STREET 1:** 28159 AVENUE STANFORD
- **STREET 2:** SUITE 220
- **CITY:** VALENCIA
- **STATE:** CA
- **ZIP:** 91355

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Avita Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20200630

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Avita Medical, Ltd.
- **DATE OF NAME CHANGE:** 20181218

<br>![img208000246_0.gif](img208000246_0.gif)

28159 Avenue Stanford, Suite 220, Valencia, CA 91355

**T** (833) 462-8482 **W** AVITAmedical.com

April 7, 2026

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Nicholas O'Leary

Re: &nbsp;&nbsp;&nbsp;&nbsp;AVITA Medical, Inc.

Registration Statement on Form S-3

Filed on March 31, 2026

File No. 333-294790

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the "Securities Act"), registrant AVITA Medical, Inc. (the "Registrant") hereby respectfully requests that the above-referenced Registration Statement on Form S-3 be declared effective at 4:30 p.m., Eastern Time, on April 9, 2026 or as soon thereafter as is practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Commission.

Please direct any questions regarding this request to Coleman Wombwell of K&L Gates LLP ((704) 331-7551; coleman.wombwell@klgates.com). In addition, please notify Mr. Wombwell when this request for acceleration has been granted.

Sincerely,

/s/ Nicole Kelsey

Nicole Kelsey

Chief Legal and Compliance Officer

AVITA Medical, Inc.

------